Lobe Sciences Ltd.
Research Lobe Sciences Ltd. (LOBE) on Bullrun: market cap EUR 13.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLOBE
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 13.64M
- Financial periodQ4 2025
- Net income-EUR 916.14K
- Free cash flow-EUR 579.01K
Valuation Snapshot
latest market cap is EUR 13.64M.
About Lobe Sciences Ltd.
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada.
Frequently asked questions
What is Lobe Sciences Ltd.'s market cap?
Lobe Sciences Ltd.'s market capitalization is EUR 13.64M.
What does Lobe Sciences Ltd. do?
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd.